Posts tagged with ‘faqs’

Trade Mark Update: April 2018
Innofy's review of most noteworthy Australian Trade Mark Office (ATMO) decisions handed down in recent months - to May 2018.
Is the recent BMS-Nektar NKTR-214 deal really the most lucrative agreement in biotech history?
Bristol-Myers Squibb (BMS) and Nektar Therapeutics (Nektar) have agreed to a Global Development & Commercialisation Collaboration, to work on Nektar’s…
Innofy Present at Global Innovation Conference
The IP team at Innofy were recently invited to present at the Global Creative Innovation Conference 2017 in Melbourne, Australia.…